Compound Library

SARM / Classic SARM

ACP-105

Partial AR agonist with CNS penetration. Potential neuroprotective and cognitive benefits. Very early research stage.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose1–5 mg/day
Half-life6 hours
Risk flagmoderate
Regulatory noteResearch-only flag

Side effects and watch-outs

  • HPTA suppression
  • ⚠️ Extremely limited human safety data — no completed human trials
  • Unknown long-term effects
  • Liver enzyme elevation possible